National Research (NRC) Stock Overview
Provides analytics and insights that facilitate measurement and improvement of the patient and employee experience. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 1/6 |
| Financial Health | 2/6 |
| Dividends | 2/6 |
NRC Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
National Research Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$11.66 |
| 52 Week High | US$21.64 |
| 52 Week Low | US$9.76 |
| Beta | 0.43 |
| 1 Month Change | -12.33% |
| 3 Month Change | -16.33% |
| 1 Year Change | -35.08% |
| 3 Year Change | -71.66% |
| 5 Year Change | -77.49% |
| Change since IPO | -41.70% |
Recent News & Updates
The Market Doesn't Like What It Sees From National Research Corporation's (NASDAQ:NRC) Earnings Yet As Shares Tumble 27%
Oct 10
Returns On Capital Signal Tricky Times Ahead For National Research (NASDAQ:NRC)
Sep 26National Research (NASDAQ:NRC) Will Pay A Dividend Of $0.12
Aug 28Recent updates
The Market Doesn't Like What It Sees From National Research Corporation's (NASDAQ:NRC) Earnings Yet As Shares Tumble 27%
Oct 10Returns On Capital Signal Tricky Times Ahead For National Research (NASDAQ:NRC)
Sep 26National Research (NASDAQ:NRC) Will Pay A Dividend Of $0.12
Aug 28Risks Still Elevated At These Prices As National Research Corporation (NASDAQ:NRC) Shares Dive 26%
Aug 04A Look At The Intrinsic Value Of National Research Corporation (NASDAQ:NRC)
Jul 16There's Reason For Concern Over National Research Corporation's (NASDAQ:NRC) Massive 26% Price Jump
Jun 20National Research (NASDAQ:NRC) Has Affirmed Its Dividend Of $0.12
May 02Lacklustre Performance Is Driving National Research Corporation's (NASDAQ:NRC) 30% Price Drop
Apr 22National Research (NASDAQ:NRC) Has Announced A Dividend Of $0.12
Mar 28Does National Research (NASDAQ:NRC) Have A Healthy Balance Sheet?
Feb 22National Research (NASDAQ:NRC) Is Due To Pay A Dividend Of $0.12
Dec 23National Research (NASDAQ:NRC) Is Due To Pay A Dividend Of $0.12
Dec 03National Research (NASDAQ:NRC) Is Due To Pay A Dividend Of $0.12
Jun 19National Research Corporation's (NASDAQ:NRC) Shares May Have Run Too Fast Too Soon
Jun 04Estimating The Fair Value Of National Research Corporation (NASDAQ:NRC)
May 09National Research's (NASDAQ:NRC) Dividend Will Be $0.12
Feb 20National Research (NASDAQ:NRC) Will Pay A Dividend Of $0.12
Dec 13Many Would Be Envious Of National Research's (NASDAQ:NRC) Excellent Returns On Capital
Oct 01We Think National Research (NASDAQ:NRC) Can Stay On Top Of Its Debt
Jul 10Why We Like The Returns At National Research (NASDAQ:NRC)
May 04Does National Research (NASDAQ:NRC) Have A Healthy Balance Sheet?
Mar 25Shareholder Returns
| NRC | US Healthcare | US Market | |
|---|---|---|---|
| 7D | 0.4% | 1.1% | 2.0% |
| 1Y | -35.1% | -14.4% | 17.9% |
Return vs Industry: NRC underperformed the US Healthcare industry which returned -14.5% over the past year.
Return vs Market: NRC underperformed the US Market which returned 17.8% over the past year.
Price Volatility
| NRC volatility | |
|---|---|
| NRC Average Weekly Movement | 6.5% |
| Healthcare Industry Average Movement | 6.4% |
| Market Average Movement | 6.5% |
| 10% most volatile stocks in US Market | 17.4% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: NRC has not had significant price volatility in the past 3 months compared to the US market.
Volatility Over Time: NRC's weekly volatility (7%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1981 | 368 | Trent Green | www.nrchealth.com |
National Research Corporation provides analytics and insights that facilitate measurement and improvement of the patient and employee experience. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, employee engagement, reputation management, rounding, and brand loyalty. The company also offers marketing experience solutions that allow the tracking of awareness, perception, and consistency of healthcare brands; assessment of competitive differentiators; and enhanced segmentation tools to evaluate needs, wants, and behaviors of communities through real-time competitive assessments and enhanced segmentation tools.
National Research Corporation Fundamentals Summary
| NRC fundamental statistics | |
|---|---|
| Market cap | US$268.92m |
| Earnings (TTM) | US$17.84m |
| Revenue (TTM) | US$140.31m |
Is NRC overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| NRC income statement (TTM) | |
|---|---|
| Revenue | US$140.31m |
| Cost of Revenue | US$55.69m |
| Gross Profit | US$84.63m |
| Other Expenses | US$66.78m |
| Earnings | US$17.84m |
Last Reported Earnings
Jun 30, 2025
Next Earnings Date
Oct 27, 2025
| Earnings per share (EPS) | 0.77 |
| Gross Margin | 60.31% |
| Net Profit Margin | 12.72% |
| Debt/Equity Ratio | 379.6% |
How did NRC perform over the long term?
See historical performance and comparisonDividends
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/10/26 14:50 |
| End of Day Share Price | 2025/10/24 00:00 |
| Earnings | 2025/06/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
National Research Corporation is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Ryan Daniels | William Blair & Company L.L.C. |